Slingshot members are tracking this event:
FDA Concludes that Johnson & Johnson's (JNJ) Blood Thinner XARELTO is Safer Than Bristol-Myers Squibb's (BMY) Warfarin in Patients with Atrial Fibrillation
- Source Link:
Slingshot Insights Explained
Oct 11, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Blood Thinner, Xarelto, Warfarin, Atrial Fibrillation, Fda, Phase 3, Rocket-af, Inratio Device